Company record
Abbott Diabetes Care, Inc.
1 FDA warning letter since 2023 and 4 recalls in the last 12 months.
Get an email the day FDA posts anything new about Abbott Diabetes Care, Inc..
Warning letters
-
DevicesAbbott Diabetes Care, Inc.
FDA warns Abbott Diabetes Care that FreeStyle Libre 3 glucose monitors lacked design transfer and finished-device accuracy release testing.
High risk
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jan 21 | Class I | Abbott Diabetes Care, Inc. Device |
FreeStyle Libre 3 Sensor REF 72081-01 UDI-DI code: 00357599818005 The FreeStyle Libre 3 sensor is a component of the FreeStyle Libre 3 Continuous Glucose Monitoring System. Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results |
| Jan 21 | Class I | Abbott Diabetes Care, Inc. Device |
FreeStyle Libre 3 Plus Sensor REF 78768-01 UDI-DI code: 00357599844011 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glucose Monitoring System. Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results |
| Jan 21 | Class I | Abbott Diabetes Care, Inc. Device |
FreeStyle Libre 3 Plus Sensor REF 78769-01 UDI-DI code: 00357599843014 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glucose Monitoring System. Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results |
| Jan 21 | Class I | Abbott Diabetes Care, Inc. Device |
FreeStyle Libre 3 Plus Sensor REF 72080-01 UDI-DI code: 00357599819002 The FreeStyle Libre 3 Plus sensor is a component of the FreeStyle Libre 3 Continuous Glucose Monitoring System. Due to a manufacturing process issue that may cause carbon build up in the sensor that may result in incorrect low glucose results |